Anthony Bui, MD
Urology · Vancouver, WANPI 1598325805
Payments from drug & device makers
What this record shows
This record is dominated by grants: $50,000 of the $55,124 with a category attached, or 90.7%. Boston Scientific accounts for 95.9% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $51,288 and has fallen 98.9% since, to $586 in 2025. Among urology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $664.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$53K
- Coloplast$1K
- Pfizer$200
- Biotissue Holdings Inc.$153
- Olympus America Inc.$146
- Endo USA, Inc.$125
- plus $403 from 9 others
What the payments were for
- Grants$50,00091%
- Travel & lodging$1,3102%
- Food & beverage$3,8147%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 37 | $52,837 |
| Coloplast | 19 | $1,260 |
| Pfizer | 11 | $200 |
| Biotissue Holdings Inc. | 2 | $153 |
| Olympus America Inc. | 1 | $146 |
| Endo USA, Inc. | 1 | $125 |
| Myriad Genetic Laboratories, Inc. | 1 | $95 |
| Merck | 3 | $63 |
| 180 Medical, Inc. | 1 | $53 |
| Antares Pharma, Inc. | 1 | $50 |
| Novartis | 2 | $45 |
| Blue Earth Diagnostics | 1 | $30 |
| AstraZeneca | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| AbbVie | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$1,110
- LithoVue$164
- AMS 700$148
- Gyrus ACMI$146
- Soltive$146
- GENERAL ERECTILE DYSFUNCTION$140
- XIAFLEX$125
- NEOX$125
- CLARIX$125
- rezum Generator$117
How this compares
$55,124 in reported general payments places this provider in the 95th percentile of 274 urology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $53 |
| Ibuprofen | 13 | $25 |
| Oxycodone Hcl | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other urology in Vancouver
- Alan BickelVancouver$18K
- James PorterSeattle$471K
- Marah HehemannSeattle$213K
- Raymond LanceSpokane$211K
- Thomas WalshSeattle$186K
- Alvaro LucioniSeattle$148K
- Una LeeSeattle$116K
- George SchadeSeattle$78K
- Kevin OstrowskiKirkland$64K
- Marco SalazarEdmonds$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.